Fred Alger Management’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-8,000
| Closed | -$179K | – | 578 |
|
|
2019
Q1 | $179K | Buy |
8,000
+4,500
| +129% | +$101K | ﹤0.01% | 398 |
|
|
2018
Q4 | $64K | Sell |
3,500
-10,500
| -75% | -$192K | ﹤0.01% | 391 |
|
|
2018
Q3 | $253K | Hold |
14,000
| – | – | ﹤0.01% | 382 |
|
|
2018
Q2 | $139K | Hold |
14,000
| – | – | ﹤0.01% | 388 |
|
|
2018
Q1 | $74K | Sell |
14,000
-3,000
| -18% | -$15.9K | ﹤0.01% | 415 |
|
|
2017
Q4 | $145K | Sell |
17,000
-13,000
| -43% | -$111K | ﹤0.01% | 407 |
|
|
2017
Q3 | $438K | Sell |
30,000
-3,000
| -9% | -$43.8K | ﹤0.01% | 359 |
|
|
2017
Q2 | $618K | Buy |
33,000
+15,000
| +83% | +$281K | ﹤0.01% | 356 |
|
|
2017
Q1 | $383K | Buy |
18,000
+3,346
| +23% | +$71.2K | ﹤0.01% | 370 |
|
|
2016
Q4 | $223K | Buy |
+14,654
| New | +$223K | ﹤0.01% | 347 |
|